On April 5, Almazov Centre hosted the International Scientific and Practical Conference on Pharmacogenomics in Oncopediatrics. The event was held as part of the programme of the WCRC for Personalized Medicine with support from the Russian Ministry of Science and Higher Education.
The conference focused on the role of pharmacogenomics in improving the efficacy of anti-tumor therapies and in predicting and preventing drug-associated toxicity in patients with cancer and pediatric hematological malignancies.
Experts devoted their attention to the most important and unresolved issues of modern diagnostic modalities, the possibilities of molecular genetic testing in routine clinical practice, and the timing and indications for the above diagnostics.
They discussed targeted therapy as an option for personalized cancer treatment, and the prospects of creating a genetic portrait of the patient as a basis for rational pharmacotherapy. Modern chemotherapy perspectives, supportive treatments and complex clinical cases were presented.
The conference brought together pediatric oncologists, specialists in molecular genetic testing, geneticists, clinical pharmacologists, hematologists, endocrinologists, cardiologists and pediatricians.